Fagron delivers topline growth of 21.5% to €173 millionFagron delivers topline growth of 21.5% to €173 million

Fagron delivers topline growth of 21.5% to €173 million

2 years ago

Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 13 October 2022 – 7.00 AM CET Fagron delivers topline growth of 21.5% to €173…

Enterin and Parkinson’s UK Announce Research Collaboration in Parkinson’s DementiaEnterin and Parkinson’s UK Announce Research Collaboration in Parkinson’s Dementia

Enterin and Parkinson’s UK Announce Research Collaboration in Parkinson’s Dementia

2 years ago

PHILADELPHIA, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Enterin Inc., a privately held, Philadelphia-based, clinical-stage biopharmaceutical company developing novel treatments for neurodegenerative…

DICE Announces Pricing of Upsized Public Offering of Common StockDICE Announces Pricing of Upsized Public Offering of Common Stock

DICE Announces Pricing of Upsized Public Offering of Common Stock

2 years ago

SOUTH SAN FRANCISCO, Calif., Oct. 12, 2022 (GLOBE NEWSWIRE) -- DICE Therapeutics, Inc. (Nasdaq: DICE), a biopharmaceutical company leveraging its…

Castellum, Inc. Announces Pricing of $3,000,000 Public Offering and NYSE ListingCastellum, Inc. Announces Pricing of $3,000,000 Public Offering and NYSE Listing

Castellum, Inc. Announces Pricing of $3,000,000 Public Offering and NYSE Listing

2 years ago

POTOMAC, Md., Oct. 12, 2022 (GLOBE NEWSWIRE) -- Castellum, Inc. (NYSE: CTM) (“Castellum”, or the “Company”), a cybersecurity, electronic warfare,…

BioSyent Initiates First DividendBioSyent Initiates First Dividend

BioSyent Initiates First Dividend

2 years ago

MISSISSAUGA, Ontario, Oct. 12, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce…

Ocugen Announces Completion of Dosing in OCU400 Phase 1/2 Cohort 2Ocugen Announces Completion of Dosing in OCU400 Phase 1/2 Cohort 2

Ocugen Announces Completion of Dosing in OCU400 Phase 1/2 Cohort 2

2 years ago

•  No safety concerns noted in ongoing clinical trial•  Study timeline remains on track MALVERN, Pa., Oct. 12, 2022 (GLOBE…

Axiom Exhibiting at Outsourcing in Clinical Trials New England 2022Axiom Exhibiting at Outsourcing in Clinical Trials New England 2022

Axiom Exhibiting at Outsourcing in Clinical Trials New England 2022

2 years ago

TORONTO, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), a premier provider of unified eClinical solutions and services…

Loos, France, Isovital Headquarter, Oct 12th 2022 – Radiopharma Logistics Group (RLG); ISOTOPES SERVICES INTERNATIONAL (ISI). NEW SHAREHOLDERLoos, France, Isovital Headquarter, Oct 12th 2022 – Radiopharma Logistics Group (RLG); ISOTOPES SERVICES INTERNATIONAL (ISI). NEW SHAREHOLDER

Loos, France, Isovital Headquarter, Oct 12th 2022 – Radiopharma Logistics Group (RLG); ISOTOPES SERVICES INTERNATIONAL (ISI). NEW SHAREHOLDER

2 years ago

Loos, France, Isovital Headquarter, Oct 12th 2022 - Radiopharma Logistics Group (RLG); ISOTOPES SERVICES INTERNATIONAL (ISI). NEW SHAREHOLDERClaude Poliart, founder and manager…

Codex DNA Announces Plan to Change Corporate Name to Telesis BioCodex DNA Announces Plan to Change Corporate Name to Telesis Bio

Codex DNA Announces Plan to Change Corporate Name to Telesis Bio

2 years ago

Novel name reflects expansion of capabilities and solutionsSAN DIEGO, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY),…

SciSparc Ltd. Announces Receipt of Nasdaq Minimum Bid Price NotificationSciSparc Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification

SciSparc Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification

2 years ago

TEL AVIV, Israel, Oct. 12, 2022 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC), a specialty clinical-stage pharmaceutical company focusing on…